Long-term endoscopic surveillance of patients with Barrett's esophagus.: Incidence of dysplasia and adenocarcinoma:: A prospective study

被引:188
作者
Conio, M
Blanchi, S
Lapertosa, G
Ferraris, R
Sablich, R
Marchi, S
D'Onofrio, V
Lacchin, T
Iaquinto, G
Missale, G
Ravelli, P
Cestari, R
Benedetti, G
Macrì, G
Fiocca, R
Munizzi, F
Filiberti, R
机构
[1] Natl Inst Canc Res, Dept Gastroenterol, I-16145 Genoa, Italy
[2] Natl Inst Canc Res, Dept Environm Epidemiol, I-16145 Genoa, Italy
[3] Univ Genoa, Dept Pathol, Genoa, Italy
[4] Osped Mauriziano Umberto 1, Dept Gastroenterol, Turin, Italy
[5] Osped Civile, Dept Gastroenterol, Pordenone, Italy
[6] Univ Pisa, Dept Gastroenterol, Pisa, Italy
[7] Osped Moscati, Dept Gastroenterol, Avellino, Italy
[8] Univ Brescia, Div Endoscopy, Brescia, Italy
[9] Osped Civile, Dept Gastroenterol, Seriate, Italy
[10] Univ Florence, Dept Gastroenterol, Florence, Italy
关键词
HIGH-GRADE DYSPLASIA; ESOPHAGOGASTRIC JUNCTION; INTESTINAL METAPLASIA; GASTRIC-CARCINOMA; RISING INCIDENCE; CANCER-RISK; FOLLOW-UP; PREVALENCE; DIAGNOSIS; ASSOCIATION;
D O I
10.1016/S0002-9270(03)00629-4
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
OBJECTIVE: Barrett's esophagus (BE) is a premalignant condition for which regular endoscopic follow-up is usually advised. We evaluated the incidence of esophageal adenocarcinoma (AC) in patients with BE and the impact of endoscopic surveillance on mortality from AC. METHODS: A cohort of newly diagnosed BE patients was studied prospectively. Endoscopic and histological surveillance was recommended every 2 yr. Follow-up status was determined from hospital and registry office records and telephone calls to the patients. RESULTS: From 1987 to 1997, BE was diagnosed in 177 patients. We excluded three with high-grade dysplasia (HGD) at the time of enrollment. Follow-up was complete in 166 patients (135 male, 31 female). The mean length of endoscopic follow-up was 5.5 yr (range 0.5-13.3). Lowgrade dysplasia (LGD) was present initially in 16 patients (9.6%) and found during follow-up in another 24 patients. However, in 75% of cases, LGD was not confirmed on later biopsies. HGD was found during surveillance in three patients (1.8%), one with simultaneous AC; two with HGD developed AC later. AC was detected in five male patients during surveillance. The incidence of AC was 1/220 (5/ 1100) patient-years of total follow-up, or 1/183.6 (5/918) patient-years in subjects undergoing endoscopy. Four AC patients died, and one was alive with advanced-stage tumor. The mean number of endoscopies performed for surveillance, rather than for symptoms, was 2.4 (range 1-10) per patient. During the follow-up years the cohort had a total of 528 examinations and more than 4000 biopsies. CONCLUSIONS: The incidence of AC in BE is low, confirming recent data from the literature reporting an overestimation of cancer risk in these patients. In our patient cohort, surveillance involved a large expenditure of effort but did not prevent any cancer deaths. The benefit of surveillance remains uncertain. (C) 2003 by Am. Coll. of Gastroenterology.
引用
收藏
页码:1931 / 1939
页数:9
相关论文
共 64 条
  • [1] Variable pathologic interpretation of columnar lined esophagus by general pathologists in community practice
    Alikhan, M
    Rex, D
    Khan, A
    Rahmani, E
    Cummings, O
    Ulbright, TM
    [J]. GASTROINTESTINAL ENDOSCOPY, 1999, 50 (01) : 23 - 26
  • [2] Barrett's oesophagus: results from a 13-year surveillance programme
    Bani-Hani, K
    Sue-Ling, H
    Johnston, D
    Axon, ATR
    Martin, IG
    [J]. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2000, 12 (06) : 649 - 654
  • [3] RISING INCIDENCE OF ADENOCARCINOMA OF THE ESOPHAGUS AND GASTRIC CARDIA
    BLOT, WJ
    DEVESA, SS
    KNELLER, RW
    FRAUMENI, JF
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1991, 265 (10): : 1287 - 1289
  • [4] Bollschweiler E, 2001, CANCER, V92, P549, DOI 10.1002/1097-0142(20010801)92:3<549::AID-CNCR1354>3.0.CO
  • [5] 2-L
  • [6] BONELLI L, 1991, INT J CANCER, V48, P364
  • [7] ADENOCARCINOMA OF THE ESOPHAGOGASTRIC JUNCTION AND BARRETTS-ESOPHAGUS
    CAMERON, AJ
    LOMBOY, CT
    PERA, M
    CARPENTER, HA
    [J]. GASTROENTEROLOGY, 1995, 109 (05) : 1541 - 1546
  • [8] Cameron AJ, 1997, AM J GASTROENTEROL, V92, P586
  • [9] THE INCIDENCE OF ADENOCARCINOMA IN COLUMNAR-LINED (BARRETTS) ESOPHAGUS
    CAMERON, AJ
    OTT, BJ
    PAYNE, WS
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1985, 313 (14) : 857 - 859
  • [10] Small adenocarcinomas of the esophagogastric junction: Association with intestinal metaplasia and dysplasia
    Cameron, AJ
    Souto, EO
    Smyrk, TC
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2002, 97 (06) : 1375 - 1380